SMDT1 variants impair EMRE-mediated mitochondrial calcium uptake in patients with muscle involvement

SMDT1 变异会损害肌肉受累患者的 EMRE 介导的线粒体钙摄取

阅读:9
作者:Elianne P Bulthuis, Merel J W Adjobo-Hermans, Bastiaan de Potter, Saskia Hoogstraten, Lisanne H T Wezendonk, Omar A Z Tutakhel, Liesbeth T Wintjes, Bert van den Heuvel, Peter H G M Willems, Erik-Jan Kamsteeg, M Estela Rubio Gozalbo, Suzanne C E H Sallevelt, Suzanne M Koudijs, Joost Nicolai, Charlott

Abstract

Ionic calcium (Ca2+) is a key messenger in signal transduction and its mitochondrial uptake plays an important role in cell physiology. This uptake is mediated by the mitochondrial Ca2+ uniporter (MCU), which is regulated by EMRE (essential MCU regulator) encoded by the SMDT1 (single-pass membrane protein with aspartate rich tail 1) gene. This work presents the genetic, clinical and cellular characterization of two patients harbouring SMDT1 variants and presenting with muscle problems. Analysis of patient fibroblasts and complementation experiments demonstrated that these variants lead to absence of EMRE protein, induce MCU subcomplex formation and impair mitochondrial Ca2+ uptake. However, the activity of oxidative phosphorylation enzymes, mitochondrial morphology and membrane potential, as well as routine/ATP-linked respiration were not affected. We hypothesize that the muscle-related symptoms in the SMDT1 patients result from aberrant mitochondrial Ca2+ uptake.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。